Effects of aging on cardiac extracellular matrix in men and women

Proteomics - Clinical Applications

Volumn 10, Issue 1, 2016, Pages 84-91

  Dworatzek, Elke ^a,b   Baczko, Istvan ^c   Kararigas, Georgios ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Aging; Extracellular matrix; Heart

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGEN TYPE 6; GELATINASE A; GELATINASE B; SCLEROPROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSCRIPTION FACTOR RUNX2; VIMENTIN; VINCULIN;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; CARDIAC MUSCLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; EXTRACELLULAR MATRIX; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; AGING; CARDIOVASCULAR DISEASES; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM;

EID: 84953368595     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201500031     Document Type: Article

References (45)

1. Lakatta, E. G., Levy, D., Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation 2003, 107, 346-354.
2. Swynghedauw, B., Molecular mechanisms of myocardial remodeling. Physiol. Rev. 1999, 79, 215-262.
3. Chakraborti, S., Mandal, M., Das, S., Mandal, A., Chakraborti, T., Regulation of matrix metalloproteinases: an overview. Mol. Cell. Biochem. 2003, 253, 269-285.
4. Shi, Y., Massague, J., Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113, 685-700.
5. Rienks, M., Papageorgiou, A. P., Frangogiannis, N. G., Heymans, S., Myocardial extracellular matrix: an ever-changing and diverse entity. Circ. Res. 2014, 114, 872-888.
6. Hynes, R. O., The extracellular matrix: not just pretty fibrils. Science 2009, 326, 1216-1219.
7. Baudino, T. A., Carver, W., Giles, W., Borg, T. K., Cardiac fibroblasts: friend or foe? Am. J. Physiol. Heart Circ. Physiol. 2006, 291, H1015-H1026.
8. Lieber, S. C., Qiu, H., Chen, L., Shen, Y. T. et al., Cardiac dysfunction in aging conscious rats: altered cardiac cytoskeletal proteins as a potential mechanism. Am. J. Physiol. Heart Circ. Physiol. 2008, 295, H860-H866.
9. Eghbali, M., Robinson, T. F., Seifter, S., Blumenfeld, O. O., Collagen accumulation in heart ventricles as a function of growth and aging. Cardiovasc. Res. 1989, 23, 723-729.
10. Nguyen, C. T., Hall, C. S., Scott, M. J., Zhu, Q. et al., Age-related alterations of cardiac tissue microstructure and material properties in Fischer 344 rats. Ultrasound Med. Biol. 2001, 27, 611-619.
11. Burgess, M. L., McCrea, J. C., Hedrick, H. L., Age-associated changes in cardiac matrix and integrins. Mech. Ageing Dev. 2001, 122, 1739-1756.
12. Lindsey, M. L., Goshorn, D. K., Squires, C. E., Escobar, G. P. et al., Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function. Cardiovasc. Res. 2005, 66, 410-419.
13. Bradshaw, A. D., Baicu, C. F., Rentz, T. J., Van Laer, A. O. et al., Age-dependent alterations in fibrillar collagen content and myocardial diastolic function: role of SPARC in post-synthetic procollagen processing. Am. J. Physiol. Heart Circ. Physiol. 2010, 298, H614-H622.
14. Dai, D. F., Santana, L. F., Vermulst, M., Tomazela, D. M. et al., Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 2009, 119, 2789-2797.
15. de Castro Bras, L. E., Toba, H., Baicu, C. F., Zile, M. R. et al., Age and SPARC change the extracellular matrix composition of the left ventricle. BioMed. Res. Int. 2014, 2014, 810562.
16. Stein, M., Noorman, M., van Veen, T. A., Herold, E. et al., Dominant arrhythmia vulnerability of the right ventricle in senescent mice. Heart Rhythm 2008, 5, 438-448.
17. Horn, M. A., Graham, H. K., Richards, M. A., Clarke, J. D. et al., Age-related divergent remodeling of the cardiac extracellular matrix in heart failure: collagen accumulation in the young and loss in the aged. J. Mol. Cell Cardiol. 2012, 53, 82-90.
18. Dworatzek, E., Mahmoodzadeh, S., Schubert, C., Westphal, C. et al., Sex differences in exercise-induced physiological myocardial hypertrophy are modulated by oestrogen receptor beta. Cardiovasc. Res. 2014, 102, 418-428.
19. Petrov, G., Dworatzek, E., Schulze, T. M., Dandel, M. et al., Maladaptive remodeling is associated with impaired survival in women but not in men after aortic valve replacement. JACC Cardiovasc. Imaging 2014, 7, 1073-1080.
20. Mendes, A. B., Ferro, M., Rodrigues, B., Souza, M. R. et al., Quantification of left ventricular myocardial collagen system in children, young adults, and the elderly. Medicina 2012, 72, 216-220.
21. Krieg, T., Le Roy, E. C., Diseases of the extracellular matrix. J. Mol. Med. 1998, 76, 224-225.
22. Kong, P., Christia, P., Frangogiannis, N. G., The pathogenesis of cardiac fibrosis. Cell. Mol. Life Sci. 2014, 71, 549-574.
23. Frangogiannis, N. G., Matricellular proteins in cardiac adaptation and disease. Physiol. Rev. 2012, 92, 635-688.
24. Martos, R., Baugh, J., Ledwidge, M., O'Loughlin, C. et al., Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007, 115, 888-895.
25. de Jong, S., van Veen, T. A., van Rijen, H. V., de Bakker, J. M., Fibrosis and cardiac arrhythmias. J. Cardiovasc. Pharmacol. 2011, 57, 630-638.
26. Kwak, H. B., Kim, J. H., Joshi, K., Yeh, A. et al., Exercise training reduces fibrosis and matrix metalloproteinase dysregulation in the aging rat heart. FASEB J. 2011, 25, 1106-1117.
27. Cleland, J. G., Swedberg, K., Follath, F., Komajda, M. et al., The EuroHeart failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur. Heart J. 2003, 24, 442-463.
28. Drici, M. D., Knollmann, B. C., Wang, W. X., Woosley, R. L., Cardiac actions of erythromycin: influence of female sex. JAMA 1998, 280, 1774-1776.
29. Lehmann, M. H., Hardy, S., Archibald, D., MacNeil, D. J., JTc prolongation with d, l-sotalol in women versus men. Am. J. Cardiol. 1999, 83, 354-359.
30. Reinoehl, J., Frankovich, D., Machado, C., Kawasaki, R. et al., Probucol-associated tachyarrhythmic events and QT prolongation: importance of gender. Am. Heart J. 1996, 131, 1184-1191.
31. Rodriguez, L. M., de Chillou, C., Schlapfer, J., Metzger, J. et al., Age at onset and gender of patients with different types of supraventricular tachycardias. Am. J. Cardiol. 1992, 70, 1213-1215.
32. Mahmoodzadeh, S., Dworatzek, E., Fritschka, S., Pham, T. H., Regitz-Zagrosek, V., 17beta-Estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts. Cardiovasc. Res. 2010, 85, 719-728.
33. Mahmoodzadeh, S., Pham, T. H., Kuehne, A., Fielitz, B. et al., 17beta-Estradiol-induced interaction of ERalpha with NPPA regulates gene expression in cardiomyocytes. Cardiovasc. Res. 2012, 96, 411-421.
34. Petrov, G., Regitz-Zagrosek, V., Lehmkuhl, E., Krabatsch, T. et al., Regression of myocardial hypertrophy after aortic valve replacement: faster in women? Circulation 2010, 122, S23-S28.
35. Kararigas, G., Becher, E., Mahmoodzadeh, S., Knosalla, C. et al., Sex-specific modification of progesterone receptor expression by 17beta-oestradiol in human cardiac tissues. Biol. Sex Differ. 2010, 1, 2.
36. Kararigas, G., Bito, V., Tinel, H., Becher, E. et al., Transcriptome characterization of estrogen-treated human myocardium identifies Myosin regulatory light chain interacting protein as a sex-specific element influencing contractile function. J. Am. Coll. Cardiol. 2012, 59, 410-417.
37. Kararigas, G., Nguyen, B. T., Jarry, H., Estrogen modulates cardiac growth through an estrogen receptor alpha-dependent mechanism in healthy ovariectomized mice. Mol. Cell. Endocrinol. 2014, 382, 909-914.
38. Kararigas, G., Nguyen, B. T., Zelarayan, L. C., Hassenpflug, M. et al., Genetic background defines the regulation of postnatal cardiac growth by 17beta-estradiol through a beta-catenin mechanism. Endocrinology 2014, 155, 2667-2676.
39. Kararigas, G., Fliegner, D., Forler, S., Klein, O. et al., Comparative proteomic analysis reveals sex and estrogen receptor beta effects in the pressure overloaded heart. J. Proteome Res. 2014, 13, 5829-5836.
40. Kararigas, G., Fliegner, D., Gustafsson, J. A., Regitz-Zagrosek, V., Role of the estrogen/estrogen-receptor-beta axis in the genomic response to pressure overload-induced hypertrophy. Physiol. Genomics 2011, 43, 438-446.
41. Kararigas, G., Dworatzek, E., Petrov, G., Summer, H. et al., Sex-dependent regulation of fibrosis and inflammation in human left ventricular remodelling under pressure overload. Eur. J. Heart Fail 2014, 16, 1160-1167.
42. Petrov, G., Dworatzek, E., Schulze, T., Dandel, M. et al., Maladaptive remodeling is associated with impaired survival in women but not in men after aortic valve replacement. JACC Cardiovasc. Imaging 2014, 7, 1073-1080.
43. Norris, R. A., Damon, B., Mironov, V., Kasyanov, V. et al., Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J. Cell. Biochem. 2007, 101, 695-711.
44. Oka, T., Xu, J., Kaiser, R. A., Melendez, J. et al., Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ. Res. 2007, 101, 313-321.
45. Yang, Y. C., Piek, E., Zavadil, J., Liang, D. et al., Hierarchical model of gene regulation by transforming growth factor beta. Proc. Natl. Acad. Sci. USA 2003, 100, 10269-10274.